Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence of Homologous Recombination Pathway Gene Mutations in Melanoma: Rationale for a New Targeted Therapeutic Approach.
Kim KB, Soroceanu L, de Semir D, Millis SZ, Ross J, Vosoughi E, Dar AA, Nosrati M, Desprez PY, Ice R, Chen M, Chetal K, Bhattacharjee A, Moretto J, Leong SP, Singer MI, Parrett BM, Minor DR, McAllister S, Miller JR 3rd, Salomonis N, Kashani-Sabet M. Kim KB, et al. Among authors: minor dr. J Invest Dermatol. 2021 Aug;141(8):2028-2036.e2. doi: 10.1016/j.jid.2021.01.024. Epub 2021 Feb 19. J Invest Dermatol. 2021. PMID: 33610559 Free article.
Sunitinib therapy for melanoma patients with KIT mutations.
Minor DR, Kashani-Sabet M, Garrido M, O'Day SJ, Hamid O, Bastian BC. Minor DR, et al. Clin Cancer Res. 2012 Mar 1;18(5):1457-63. doi: 10.1158/1078-0432.CCR-11-1987. Epub 2012 Jan 18. Clin Cancer Res. 2012. PMID: 22261812
Inoperable bulky melanoma responds to neoadjuvant therapy with vemurafenib.
Fadaki N, Cardona-Huerta S, Martineau L, Thummala S, Cheng ST, Bunker SR, Garcia-Kennedy R, Wang W, Minor D, Kashani-Sabet M, Leong SP. Fadaki N, et al. BMJ Case Rep. 2012 Oct 22;2012:bcr2012007034. doi: 10.1136/bcr-2012-007034. BMJ Case Rep. 2012. PMID: 23093505 Free PMC article.
Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanoma.
Ascierto PA, Minor D, Ribas A, Lebbe C, O'Hagan A, Arya N, Guckert M, Schadendorf D, Kefford RF, Grob JJ, Hamid O, Amaravadi R, Simeone E, Wilhelm T, Kim KB, Long GV, Martin AM, Mazumdar J, Goodman VL, Trefzer U. Ascierto PA, et al. J Clin Oncol. 2013 Sep 10;31(26):3205-11. doi: 10.1200/JCO.2013.49.8691. Epub 2013 Aug 5. J Clin Oncol. 2013. PMID: 23918947 Clinical Trial.
The role of BPTF in melanoma progression and in response to BRAF-targeted therapy.
Dar AA, Nosrati M, Bezrookove V, de Semir D, Majid S, Thummala S, Sun V, Tong S, Leong SP, Minor D, Billings PR, Soroceanu L, Debs R, Miller JR 3rd, Sagebiel RW, Kashani-Sabet M. Dar AA, et al. J Natl Cancer Inst. 2015 Feb 23;107(5):djv034. doi: 10.1093/jnci/djv034. J Natl Cancer Inst. 2015. PMID: 25713167 Free PMC article.
48 results